Neurodegeneration

Non-invasive biomarkers and emerging methods for early neurodegeneration diagnosis

As the world population continues to age, neurodegenerative diseases pose  an increasing health crisis. Recent advances in detecting non-invasive biomarkers and novel diagnostic techniques have transformed the diagnosis of many of these conditions, yet early diagnosis and effective monitoring remain challenging.

Emerging protocols that explore non-invasive biomarker sources - such as olfactory mucosa, skin, blood, and circulating nucleic acids- can enhance accessibility and patient compliance.

Nevertheless, challenges persist in standardizing sample collection, validating biomarker performance, and incorporating these tools into clinical practice, aspects that are increasingly explored within the broader scientific ecosystem of CoScience HUB.